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Abstract. The effects of various flavonoids and carotenoids on
Rhodamine 123 accumulation in multidrug-resistant Colo 320
human colon cancer cells expressing MDR1/LRP were studied.
The Colo 205 cell line was used as a drug-sensitive control.
Rotenon, Catechin, Neohesperidin, Naringin, Robinin, Phloridzin,
Robinetin, Dihydrobinetin, Dihydrofisetin, Kampferol,
Dihidroquercetin, Sakuranin and Sakuranetin were tested on
Colo 320 cells: only Rotenon was found to be effective as regards
multidrug resistance (MDR) reversal, while a majority of the
flavonoids, such as Catechin, Neohesperidin, Naringin, Robinin,
Phloridzin, Dihydrobinetin and Sakuranetin, had only marginal
effects on Rhodamine 123 accumulation. The tested carotenoids
(‚-Cryptoxanthin, Luteoxanthin, Anteroxanthin, Violeoxanthin,
Apple peel fetoxanthin, Lutein, Violaxanthin and Neoxanthin)
were able to increase Rhodamine 123 accumulation in Colo 320
cells. Verapamil was applied as a resistance-modifying positive
control. The levels of apoptosis induction in drug-resistant and -
sensitive cell lines were also compared. The results indicated that
the tested flavonoids were weak apoptosis inducers on MDR and
parent cells, without significant differences. A majority of the
carotenoids induced only early apoptosis, but apoptosis and cell
death were not induced in MDR colon cancer cells. 
Cross-resistance between different cytostatic agents, which
are structurally and functionally unrelated, is a common
phenomenon, called multidrug resistance (MDR). There are
several ways that cancer cells develop resistance against
anticancer drugs (1-3). One of them is the function of efflux
pumps, whereby cells pump out drugs from the cytoplasm
(4-6). Early attempts to characterize such efflux pumps were
reviewed by Gottesman and Pastan (7). The best-
characterized mechanism of MDR involves P-glycoprotein
(P-gp), which belongs to the ATP-binding cassette (ABC)
family of transporter molecules (8). Numerous compounds
reverse MDR in experimental systems (9). This has led to
the theory of the concomitant administration of
chemotherapy and a MDR modulator to reverse clinical
drug resistance. Phenothiazines are among the compounds
known to modify MDR mediated by P-gp in various kinds
of cancer cell lines (10,11). The interactions of MDR
modulators such as phenothiazines and isoflavones with
phospholipid liposomes and multilamellar lipid structures
have also been studied (12). The MDR modulators act
mainly as "competitive" or "non-competitive" inhibitors,
resulting in an increased concentration of cytotoxic drugs in
tumor cells. Modulators such as Verapamil and cyclosporin
A serve as substrates for P-gp, supporting the hypothesis
that they behave as competitive ligands (13,14). Recently, it
was found that a large number of newly synthesized and
plant-derived compounds increase the intracellular drug
accumulation in MDR cancer cells in vitro (15). It is known
that flavonoid - and carotenoid -rich foods can be associated
with a reduced risk of the development of chronic diseases
such as cancer (16). In addition, some of these compounds
have been shown to undergo high-affinity binding to MDR
P-gp (17,18).
Various mechanisms of action have been identified in the
reversal of MDR and apoptosis induction (19,20). We
decided to investigate the MDR-reversal effects and
apoptosis induction of two large groups of plant-derived
compounds, flavonoids and carotenoids, on MDR1/LRP-
expressing colon cancer cells. 
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Materials and Methods
Chemicals. The carotenoids ‚-Cryptoxanthin, Luteoxanthin,
Anteroxanthin, Violeoxanthin, Apple peel fetoxanthin, Lutein,
Violaxanthin and Neoxanthin were isolated by Péter Molnár, while
the flavonoids Rotenon, Catechin, Neohesperidin, Naringin,
Chrysin, Robinin, Phloretin, Phloridzin, Robinetin, Dihydrobinetin,
Kampferol, Dihydrofisetin, Dihydroquercetin, Sakuranin and
Sakuranetin were isolated and identified earlier by Sándor Antus.
12H-Benzo[·]phenothiazine (M627) was synthesized by Motohashi
et al. (21). The stock solutions were prepared in dimethylsulfoxide
(DMSO). Verapamil was from EGIS (Hungarian Pharmaceutical
Company, Budapest, Hungary), Rhodamine 123 from Sigma (St.
Louis, MO, USA) and Annexin-V (human, recombinant)
fluorescein isothiocyanate (FITC) from Alexis Biochemicals
(ALEXIS DEUTSCHLAND Gmbh, Grünberg, Germany). The
human colon adenocarcinoma cell lines, ATCC-CCL-220.1 (Colo
320) and CCL-222(Colo 205), were purchased from LGC
Promochem, Teddington, England.
Cell cultures. The cells were cultured in RPMI 1640 medium
supplemented with 10% heat-inactivated fetal bovine serum, 2 mM
L-glutamine, 1 mM Na-pyruvate and 100 mM Hepes. The cell lines
were incubated in a humified atmosphere (5% CO2, 95% air) at
37ÆC. The semi-adherent human colon cancer cells were detached
with 0.25% trypsin and 0.02% EDTA for 5 min at 37ÆC. 
Assay for reversal of MDR in tumor cells. The cells were adjusted to
a density of 2x106/mL, resuspended in serum-free RPMI 1640
medium and distributed in 0.5 mL aliquots into Eppendorf
centrifuge tubes. The tested compounds were added to the samples
at various concentrations in different volumes (2.0-20 ÌL) of the
1.0 mg/mL stock solutions and the samples were then incubated for
10 min at room temperature. Ten ÌL (5.2 ÌM final concentration)
Rhodamine 123 indicator was added to the samples and the cells
were incubated for a further 20 min at 37ÆC, washed twice and
resuspended in 0.5 mL phosphate-buffered saline (PBS) for the
analysis. The fluorescence of the cell population was measured by
flow cytometry with a Beckton Dickinson FACScan instrument.
Verapamil was used as a positive control in the Rhodamine 123
exclusion experiments (22). The percentage of the control mean
fluorescence intensity (fluorescence activity ratio, FAR) was
calculated via the following equation on the basis of the measured
fluorescence values:
MDR-treated /MDR controlFAR = 
parental-treated / parental control
The shift of the maximum fluorescence peak was measured and
compared with the fluorescence maxima of the non-treated cells.
When the compounds were tested at various increasing
concentrations, the mean fluorescence of the cell population was
continuously increased and, in addition, the shift of the maximum
fluorescence peak was also increased.
Assay of drug activity on the induction of apoptosis. The cells were
adjusted to a density of 2x105/mL and were distributed in 1.0 mL
aliquots into microcentrifuge tubes. The apoptosis inducer 12H-
Benzo[·]phenothiazine was added to the samples as a positive
control at a final concentration of 50 Ìg/mL. In the case of
control cultures, 10 ÌL DMSO was added. The cells were
incubated at 37ÆC for 45 min. The samples were then centrifuged
and washed with PBS, and the cells were resuspended in 1 mL
culture medium. The drugs used for treatment were added to the
samples at a final concentration of 10 Ìg/mL. After incubation
for 24 h at 37ÆC, the cells were transferred from a 24-well plate
into Eppendorf centrifuge tubes, centrifuged and resuspended in
1.0 mL binding buffer. The samples were mixed and centrifuged
and supernatant was removed from each tube. Annexin-V-FITC
(3 ÌL/mL samples) was added to the 200 mL samples remaining
in the tubes. Controls without Annexin-V were also prepared.
The samples and controls were incubated at room temperature
for 30 min in the dark. Before the measurement of fluorescence
activity, 10 ÌL propidium iodide (from a 20 Ìg/mL stock
solution) was added to the samples and the apoptosis of the cells
was then investigated. In some cases we had no complete
apoptosis, however, positivity with only Annexin-V was found,
but not with double staining with propidium iodide and Annexin-V
simultaneously. This first membrane alteration due to
phosphatidylserin translocation was termed as early apoptosis.
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Table I. The effects of various flavonoids on the drug accumulation 
(Rhodamine 123) in MDR1/LRP-expressing human colon cancer cells
(Colo 320).
Compounds Final Fluorescence Peak 
concentration activity channel
Ìg/mL ratio
Verapamil 10 21.62 598
DMSO - 1.09 18
Rotenon 4 13.58 881
40 40.04 1433
Catechin 4 1.48 41
40 1.57 59
Neohesperidin 4 1.60 35
40 1.55 50
Naringin 4 1.91 44
40 1.18 16
Robinin 4 1.43 36
40 1.18 18
Phloridzin 4 1.26 24
40 2.81 27
Robinetin 4 1.10 26
40 0.83 15
Dihydrobinetin 4 2.01 52
40 1.48 40
Dihydrofisetin 4 1.32 57
40 1.21 21
Kampferol 4 0.46 9
40 0.81 14
Dihydroquercetin 4 0.69 16
40 0.91 15
Sakuranin 4 0.59 12
40 0.52 11
Sakuranetin 4 0.60 11
40 5.2 27
Results 
The effects of various flavonoids on the reversal of the MDR
of Colo 320 cells were studied. Verapamil was used as a
control MDR modifier in these experiments. Among the
tested flavonoids, Rotenon was found to be the most effective
resistance modulator. Catechin, Neohesperidin, Naringin,
Robinin, Phloridzin, Dihydrobinetin and Sakuranetin had
only marginal effects, while Robinetin and Dihydrofisetin
were ineffective. Kampferol, Dihydroquercetin and Sakuranin
were not able to increase the Rhodamine 123 accumulation.
The peak channel of Rotenon was shifted from 881 to 1433,
that of Catechin from 41 to 59, that of Neohesperidin from
35 to 50 and that of Sakuranetin from 11 to 27, while the
peak channel of Verapamil was found at 598. The results
indicate that the increase in drug accumulation is dose-
dependent and the change in the curve or the maximum
fluorescence represents the fluorescence of a great majority
of the treated cell population (Table I).
Another group of plant-derived hydrophobic compounds,
the carotenoids, were also tested on the reversal of MDR
on Colo 320 cells. All of the tested carotenoids increased
the Rhodamine 123 accumulation of MDR colon cancer
cells by inhibition of the efflux pump. The concentration-
dependent effect is shown in Table II. It should be noted
that the cell size and the intracellular structures of the
carotenoid-treated cells were not modified during the short-
term experiments. In all cases, the shift of the maximum
fluorescence was increased to various extents by increasing
carotenoid concentrations. In the control experiments, the
cells were treated with carotenoids and the fluorescence was
measured without Rhodamine 123 administration to check
the autofluorescence of the treated cells. In this experiment,
none of the carotenoids induced fluorescence in the cells
(data not shown).
The most effective carotenoids in elevating the Rhodamine
123 accumulation were Anteroxanthin, Violeoxanthin, Apple
peel fetoxanthin, Lutein and Violaxanthin. Moderate
increases in drug accumulation were found in the presence of
Luteoxanthin and ‚-Cryptoxanthin. Neoxanthin was shown to
be a less effective carotenoid on the drug accumulation of
Colo 320 cells. 
The effects of the flavonoids tested above were also
studied in Colo 320 MDR and Colo 205-sensitive cells. In
these experiments, moderate early apoptosis characteristics
were induced by Rotenon, Neohesperidin, Chrysin,
Phloretin, Kampferol, Dihydrofisetin and 12H-
Benzo[·]phenothiazine as control. It is interesting that
these early apoptosis characteristics were not followed by
apoptosis, and none of the compounds induced noteworthy
cell death in the MDR Colo 320 cells, except Phloridzin,
Sakuranetin and Dihydrobinetin (Table III). 
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Table II. The effects of various carotenoids on the drug accumulation 
(Rhodamine 123) in MDR1/LRP-expressing human colon cancer cells
(Colo 320).
Compounds Final FL-1 Fluorescence Peak 
concentration. activity channel
Ìg/mL ratio
Verapamil 10 383.31 14.36 319
DMSO - 37.72 1.41 35
‚-Cryptoxanthin 4 39.33 1.47 30
40 117.95 4.41 66
Luteoxanthin 4 111.45 4.17 79
40 167.89 6.29 181
Anteroxanthin 4 143.39 5.37 85
40 352.50 13.20 307
Violeoxanthin 4 359.17 13.45 296
40 437.58 16.39 385
Apple peel fetoxanthin 4 248.41 9.30 235
40 498.86 18.69 414
Lutein 4 216.36 8.10 214
40 418.79 15.69 403
Violaxanthin 4 72.40 2.71 42
40 379.00 14.20 336
Neoxanthin 4 24.93 0.93 11
40 84.84 3.17 69
Table III. The effects of various flavonoids on apoptosis in MDR1, and
LRP-expressing human colon cancer cells (Colo 320).
Samples Apoptosis and cell death
Conc. Early Apoptosis Cell 
apoptosis (%) death
Ìg/mL (%) (%)
Annexin-V 4.7 0.09 0.00
12H-Benzo[·]phenothiazine 50 10.07 24.68 0.33
Rotenon 10 11.83 4.82 1.80
Catechin 10 6.65 6.22 1.37
Neohesperidin 10 11.27 5.21 2.16
Naringin 10 6.91 3.21 0.99
Chrysin 10 11.62 4.55 1.41
Robinin 10 8.82 5.64 1.37
Phloretin 10 12.89 6.04 1.17
Phloridzin 10 9.59 6.71 4.03
Robinetin 10 6.99 4.25 1.21
Dihydrobinetin 10 7.97 4.40 3.24
Kampferol 10 10.82 7.03 1.95
Dihydrofisetin 10 10.52 6.99 0.98
Dihydroquercetin 10 8.16 6.20 1.36
Sakuranin 10 9.60 4.83 0.77
Sakuranetin 10 0.71 1.41 5.29
The effects of some selected carotenoids were also tested on
the apoptosis of Colo 320 MDR1/LRP cells. A weak early
apoptosis was observed on Colo 320 MDR1/LRP cells at 10
Ìg/mL Violeoxanthin, Apple peel fetoxanthin, Lutein,
Violaxanthin and Neoxanthin, while in the 12H-
Benzo[·]phenothiazine-treated sample marked apoptosis and
early apoptosis were induced. The early apoptosis was less
frequent than after treatment with the flavonoids. The results
may point to a particular membrane effect of carotenoids. The
carotenoids and flavonoids were not able to induce appreciable
cell death at the concentrations applied (Table IV).
For comparison, the effects of the various flavonoids were
studied on drug-sensitive Colo 205 cells. A marked early
apoptosis was observed in all of the treated cells. However, real
apoptosis induction was found only in the 12H-
Benzo[·]phenothiazine-treated cells. In the carotenoid-treated
cells, the frequency of apoptosis varied between 3 and 6 per
cent. It must be noted, that Neohesperidin-induced cell death
was more than 10 per cent (Table V). The apoptosis induction
of the carotenoids was also checked on drug-sensitive colon
cancer cells. The spontaneous early apoptosis was hardly
modified in the presence of the different carotenoids, except
for Lutein and 12H-Benzo[·]phenothiazine. The apoptosis-
inducing effect generally varied between 3 and 7 per cent,
whereas 12H-Benzo[·]phenothiazine led to over 70 per cent
apoptosis. The cell death of the carotenoid- treated cells was
found to be between 4 and 6 per cent, except for Luteoxanthin
(Table VI). 
In conclusion, we may summarize the most important
results found on the reversal of MDR in colon cancer cells.
A majority of the tested flavonoids had no effect, while a
large number of the carotenoids displayed marked drug
accumulation in the MDR colon cancer cells. None of the
flavonoids or carotenoids were able to induce significant
apoptosis and cell death in the colon cancer cells. In the
drug-sensitive colon cancer cells, the early apoptosis was
higher than in the MDR cells, but still not significant. 
Discussion
After successful surgery and/or radiotherapy, the success of
chemotherapy depends ultimately on the rate and extent of
drug-resistant cancer cell populations, which either develop
with time or by the selection of a few MDR cells from the
original, heterologous tumor. Prevention, circumvention or
reversal of the MDR phenomenon remains an elusive goal of
research (23). The flavonoids constitute an interesting group
of polyphenolic compounds with wide distribution in fruits
and vegetables. Different biological activities have been
described e.g. antiproliferative and anticarcinogenic (24).
Various compounds have been investigated in different
laboratories for the reversal of MDR, including synthetic and
naturally occurring, plant-derived compounds (25, 26).
Among the plant-derived compounds, the flavonoids and
carotenoids play a prominent role in cancer prevention (27),
but a reversal of MDR has been described only by using
retinoids (28). In vivo research has demonstrated that
quercetin can increase the antitumor activity of cisplatin and
busulfan, and it was proposed for use in conjunction with
doxorubicin and etoposide (29). The use of carotenoids, and
particularly ‚-carotene, in cancer treatment has been
in vivo 19: 433-438 (2005)
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Table IV. The effects of various carotenoids on apoptosis in MDR1/LRP-
expressing human colon cancer cells (Colo 320).
Samples Apoptosis and cell death
Conc. Early Apoptosis Cell 
apoptosis (%) death
Ìg/mL (%) (%)
Annexin-V 4.8 0.15 0.00
12H-Benzo[·]phenothiazine 50 37.08 27.40 1.98
‚-Cryptoxanthin 10 4.59 6.71 5.90
Luteoxanthin 10 3.95 4.09 3.58
Anteroxanthin 10 5.39 5.36 2.12
Violeoxanthin 10 6.91 4.88 1.94
Apple peel fetoxanthin 10 8.32 4.80 1.23
Lutein 10 7.09 4.78 2.01
Violaxanthin 10 7.35 4.15 3.53
Neoxanthin 10 6.23 5.23 3.38
Table V. The effects of various flavonoids on apoptosis in human colon
cancer cells (Colo 205).
Samples Apoptosis and cell death
Conc. Early Apoptosis Cell 
apoptosis (%) death
Ìg/mL (%) (%)
Annexin-V 9.9 2.52 0.62
12H-Benzo[·]phenothiazine 50 15.70 80.94 0.42
Rotenon 10 34.24 3.60 1.84
Catechin 10 25.45 6.91 3.35
Neohesperidin 10 11.73 4.09 12.56
Naringin 10 20.08 3.33 2.44
Chrysin 10 13.75 3.52 1.51
Robinin 10 13.63 3.88 2.65
Phloretin 10 31.24 5.37 2.09
Phloridzin 10 22.70 3.70 2.15
Robinetin 10 12.99 4.73 1.95
Dihydrobinetin 10 27.59 3.82 2.50
Kampferol 10 29.59 4.46 2.20
Dihydrofisetin 10 15.34 4.45 5.05
Dihydroquercetin 10 9.92 4.51 6.07
Sakuranin 10 9.42 3.72 5.51
Sakuranetin 10 18.60 4.42 2.95
reviewed (30) and general immunostimulant effects have
been found for ‚-carotene (31).
Since carotenoids and flavonoids have been tested for
antiproliferative effects in various tumor cell lines, a
systematic study was initiated in our laboratory in the
direction of the reversal of MDR and apoptosis induction
in colon cancer cells. In our study, the flavonoid Rotenon
was found to be the most effective resistance modulator.
Catechin, Neohesperidin, Naringin, Robinin, Phloridzin,
Dihydrobinetin and Sakuranetin had marginal effects, while
Robinetin, Dihydrofisetin, Kampferol, Dihydroquercetin
and Sakuranin were ineffective. Our results indicate that the
MDR reversal effect needs a particular chemical structure,
which exists in Rotenon, but is missing from all the other
tested flavonoids.
A majority of the tested carotenoids were able to increase
the Rhodamine 123 accumulation in Colo 320 MDR cancer
cells by inhibition of the efflux pump. In this group of
compounds, we were not able to make a clear distinction on
the basis of the structure-activity relationships. Some
carotenoids and flavonoids have been reported to influence
programmed cell death in vitro (32, 33). A majority of the
flavonoids and carotenoids had little effect on the apoptosis of
the MDR colon cancer cells, but large numbers of compounds
from the two main groups induced early apoptosis in the cell
cultures. Since the early apoptosis events were not followed by
apoptosis, we presume that the Annexin-V-positivity of
flavonoid-or carotenoid-treated cells is a consequence of the
structural alteration in the cell membrane, which results in the
translocation of phosphatidylserine molecules from the inside
to the outer surface of the membrane. Despite the relative
ineffectiveness of the compounds with regards to apoptosis
induction, it was not surprising that the drug-sensitive colon
cancer cells were more sensitive to apoptosis induction than
their MDR1/LRP-expressing counterparts. 
A comparison of the MDR-reversal and apoptosis-
inducing activities of the tested carotenoids reveals no
correlation between the two biological effects of the
carotenoids. The results concerning the reversal of MDR by
the various compounds can be exploited. With an increased
number of effective resistance modifiers, there is a rational
perspective to improve the effectiveness of traditional
chemotherapy. On the basis of current diagnostic
procedures to determine the MDR phenotype of tumor
cells, this is a realistic goal in clinical practice. In the
histological routine, the chemosensitivity / chemoresistance
of tumor cell samples is determined. In MDR tumors, the
clinician may decide on the type of chemotherapy by
considering the possible beneficial effects of new types of
combined chemotherapy. 
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